Drug discovery is the process through which potential new medicines are identified. It involves a wide range of scientific disciplines, including biology, chemistry and pharmacology. A sustained ...

As discussions intensify about how the second Trump administration will reshape the regulatory landscape for U.S.-based life sciences firms, ...

high potassium and impaired kidney function. Direct renin inhibitors Only one drug, aliskiren, is approved to treat high blood pressure, but it may not be the first choice. diarrhea, cough ...

In this week’s View, Dr. Eagle looks at the consequences of discontinuing long-term drug treatment in patients with heart failure and reduced ejection fraction (HFrEF). He then explores the effect of ...

Drug addiction is a condition in which there is uncontrolled use of a substance with a harmful outcome. Drugs overstimulate the brain’s reward circuit, producing pleasure or euphoria. With repeated ...

Correspondence to Dr Anastasia D Egorova, Cardiology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands; a.egorova{at}lumc.nl Objective Patients with a systemic right ...

The FDA has given Lupin approval for generic Entresto, and tentative approval for generic Triumeq. Kroger is cutting about 200 employees across three office sites, and Albertsons is laying off ...

The lower incidence of severe hyperkalemia and drug discontinuation due to renal events in patients with sacubitril/valsartan treatment demonstrated its superior safety compared with RAASi. This ...

has approved a new generic version of the blood pressure drug valsartan, which is also sold under the trade name Diovan. Valsartan is a widely used angiotensin II receptor blocker (ARB ...

Humulin R (insulin human) is a prescription drug that’s used to help manage high blood sugar levels caused by diabetes. Humulin R is given as an injection under the skin. Doctors prescribe ...

Because the proposed generic drug accused of infringement was a “complex” of bonded valsartan and sacubitril, the patentee Novartis needed to urge and had successfully urged that ...

Biotechnology firm Biocon said its subsidiary has received approval from the US health regulator to market a generic medication to treat chronic heart failure. Biocon Pharma has received approval of ...